Overview Intranasal Ketamine as a Sedative for Venipuncture Status: Completed Trial end date: 2016-10-01 Target enrollment: Participant gender: Summary Randomized clinical trial, controlled, double-blind, parallel two-arm. Phase: Phase 2/Phase 3 Details Lead Sponsor: Hospital de Clinicas de Porto AlegreTreatments: Hypnotics and SedativesKetaminePharmaceutical Solutions